MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
$4,396,456
EPS
$0.07
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
General and administrative costs
112,227
132,030
122,096.25
Total operating expenses
112,227
132,030
122,096.25
Loss from operations
-112,227
-132,030
-122,096.25*
Interest earned on cash and investments held in trust account
4,508,683
4,439,850
1,233,450*
Gain on extinguishment of over-allotment option liability
-
-
138,437*
Provision for credit losses
-
-
203,028.25*
Recovery of credit losses
-
-30,000
-
Total other income
4,508,683
4,469,850
1,168,858.75*
Net income (loss)
4,396,456
4,337,820
1,046,762.5
Basic EPS
0.07
0.07
0.079
Diluted EPS
0.07
0.07
0.079
Basic Average Shares
50,000,000
50,000,000
13,287,671
Diluted Average Shares
13,700,000
50,000,000
13,287,671
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest earned on cash
and investments...
$4,508,683
Total other income
$4,508,683
Net income (loss)
$4,396,456
Loss from operations
-$112,227
Total operating
expenses
$112,227
General and
administrative costs
$112,227
Buy us a coffee
Drugs Made In America Acquisition II Corp. (DMIIR)
Drugs Made In America Acquisition II Corp. (DMIIR)